COR
Cencora, Inc. · Healthcare · Medical - Distribution
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 163 | 0 | 140.71M | $39.83B | +5 | −4 |
| Q1 2026 | 165 | -4 | 143.75M | $45.15B | +4 | −9 |
| Q4 2025 | 168 | -1 | 154.98M | $52.35B | +1 | −1 |
| Q3 2025 | 24 | +1 | 95.47M | $29.83B | +1 | −1 |
| Q2 2025 | 21 | 0 | 79.61M | $23.87B | — | — |
| Q1 2025 | 18 | +1 | 37.02M | $10.29B | +2 | −1 |
| Q4 2024 | 17 | 0 | 34.14M | $7.67B | — | — |
| Q3 2024 | 16 | 0 | 25.36M | $5.70B | — | — |
| Q2 2024 | 16 | — | 24.85M | $5.60B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.15M | — | $2.06B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.15M | — | $2.06B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 4.85M | — | $1.09B | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 4.01M | — | $900.28M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 4.01M | — | $900.28M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (passive) | 1.60M | — | $359.83M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.08M | — | $244.36M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.08M | — | $244.36M | 0.4% | n/c | 1 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 1.06M | — | $238.45M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 895.21K | — | $201.69M | 0.5% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 653.01K | — | $147.12M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 371.51K | — | $83.70M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 371.51K | — | $83.70M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 355.50K | — | $80.09M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 292.67K | — | $65.94M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 255.47K | — | $57.56M | 0.3% | n/c | 1 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 235.34K | — | $53.02M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 26.52K | — | $5.97M | 0.1% | n/c | 1 | SEC ↗ |
| 27 | Marshall Wace ✦ | 6.83K | — | $1.54M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fisher Asset Management ✦ | 1.08K | — | $244,562 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3 holders, 139 shares, $43,570 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 11.30K sh · $3.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology